• S2 Episode 2: Does Your Patient Have Allergic Asthma?

  • Jul 13 2023
  • Length: 23 mins
  • Podcast

S2 Episode 2: Does Your Patient Have Allergic Asthma?

  • Summary

  • Join Drs Mike Wechsler and Mario Castro as they discuss the diagnosis and treatment of allergic asthma in the clinic.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987113). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Asthma: A Syndrome Composed of Heterogeneous Diseases https://pubmed.ncbi.nlm.nih.gov/18681077/

    Allergic Endotypes and Phenotypes of Asthma https://pubmed.ncbi.nlm.nih.gov/32037107/

    Comorbidities and the Impact of Atopic Dermatitis https://pubmed.ncbi.nlm.nih.gov/31034875/

    Biomarkers for Diagnosis and Prediction of Therapy Responses in Allergic Diseases and Asthma https://pubmed.ncbi.nlm.nih.gov/32893900/

    2023 GINA Report for Asthma https://pubmed.ncbi.nlm.nih.gov/37302397/

    Pulmonary Function Testing in the Diagnosis of Asthma: A Population Study https://pubmed.ncbi.nlm.nih.gov/22030804/

    Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management https://pubmed.ncbi.nlm.nih.gov/34673021/

    2020 NAEPP Guidelines Update and GINA 2021-Asthma Care Differences, Overlap, and Challenges https://pubmed.ncbi.nlm.nih.gov/34718214/

    Understanding the Key Issues in the Treatment of Uncontrolled Persistent Asthma With Type 2 Inflammation https://pubmed.ncbi.nlm.nih.gov/33542055/

    2020 Focused Updates to the Asthma Management Guidelines: A Report From the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group https://pubmed.ncbi.nlm.nih.gov/33280709/

    Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy: A Randomized Trial https://pubmed.ncbi.nlm.nih.gov/21536936/

    Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma https://pubmed.ncbi.nlm.nih.gov/31521831/

    Efficacy of Tezepelumab in Patients With Evidence of Severe Allergic Asthma: Results From the Phase 3 NAVIGATOR Study https://pubmed.ncbi.nlm.nih.gov/36507576/

    The Evolving Landscape of Immunotherapy for the Treatment of Allergic Conditions https://pubmed.ncbi.nlm.nih.gov/37170653/

    Omalizumab Prescribing Information https://www.gene.com/download/pdf/xolair_prescribing.pdf

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about S2 Episode 2: Does Your Patient Have Allergic Asthma?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.